Skip to content
value.today

Meadowhawk Biolabs, Inc.

Total raised
$20 M
3 rounds on record
Latest round
$5 M
Jul 2024
First round on record
Aug 2021
Today
Private
No later event on record

Funding rounds

3 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Meadowhawk Biolabs, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Jul 2024$5 MNo. 3$2 to $10 million

Meadowhawk Biolabs, Inc.: Raise no. 3, Jul 2024

Investors in this round

8 investors had bought by the notice of Jul 16, 2024: 8 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$5 M of $5 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • James Jersey · Executive Officer, Director
  • Jessica Sullivan · Executive Officer
  • Peter Glick · Executive Officer, Director
  • Herbert Hooper · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the use of proceeds: “The gross proceeds of the offering will be used for operating expenses, working capital and other general corporate purposes.”

Signed by James Jersey, Chief Executive Officer. Source: SEC Form D, newest notice filed Jul 16, 2024. Read the notice at the SEC.

equitySEC
Mar 2023$6 MNo. 2$2 to $10 million

Meadowhawk Biolabs, Inc.: Raise no. 2, Mar 2023

Investors in this round

9 investors had bought by the notice of Mar 17, 2023: 9 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$6 M of $6 M offered
Smallest investment taken
$18,553
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • James Jersey · Executive Officer, Director
  • Jessica Sullivan · Executive Officer
  • Peter Glick · Executive Officer, Director
  • Herbert Hooper · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the use of proceeds: “The gross proceeds of the offering will be used for operating expenses, working capital and other general corporate purposes.”

Signed by Jessica Sullivan, Corporate Secretary. Source: SEC Form D, newest notice filed Mar 17, 2023. Read the notice at the SEC.

equitySEC
Aug 2021$9 MNo. 1$2 to $10 million

Meadowhawk Biolabs, Inc.: Raise no. 1, Aug 2021

Investors in this round

8 investors had bought by the notice of Mar 17, 2023: 8 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$9 M of $9 M offered
Smallest investment taken
$250,000
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Glick Peter · Executive Officer, Director
  • James Jersey · Executive Officer, Director
  • Jessica Sullivan · Executive Officer
  • Herbert Hooper · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the use of proceeds: “The gross proceeds of the offering will be used for operating expenses, working capital and other general corporate purposes.”

Signed by Jessica Sullivan, Corporate Secretary. Source: SEC Form D, newest notice filed Mar 17, 2023. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Meadowhawk Biolabs, Inc. chose not to state its revenue in its newest notice of a funding round (Jul 2024).

    SEC Form D · Jul 2024

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · Jul 2024

That is all the official record says: Meadowhawk Biolabs, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Meadowhawk Biolabs, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 3 rounds above had up to 9 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Meadowhawk Biolabs, Inc.
NameRoleNamed in
James JerseyExecutive officerJul 2024
Jessica SullivanExecutive officerJul 2024
Peter GlickExecutive officerJul 2024
Glick PeterExecutive officerMar 2023
Herbert HooperDirectorJul 2024
James JerseyDirectorJul 2024
Peter GlickDirectorJul 2024
Glick PeterDirectorMar 2023